Lucy Lu, MD, has been named president and chief executive officer of Fortress Biotech’s subsidiary Avenue Therapeutics, Inc. Dr. Lu has served as interim chief executive officer of Avenue since its inception. Also, Robyn Hunter has been appointed chief financial officer of Fortress, a role formerly held by Dr. Lu. Dr. Lindsay A. Rosenwald, Fortress’ chairman, president and chief executive officer, said, “Lucy has been essential in building Avenue, and we are thrilled to announce her official ...